Cargando…

Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions

Single-chain Fv (scFv) antibodies are recombinant proteins in which the variable regions of the heavy chain (VH) and light chain (VL) are connected by a short flexible polypeptide linker. ScFvs have the advantages of easy genetic manipulation and low-cost production using Escherichia coli compared w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamauchi, Soichiro, Kobashigawa, Yoshihiro, Fukuda, Natsuki, Teramoto, Manaka, Toyota, Yuya, Liu, Chenjiang, Ikeguchi, Yuka, Sato, Takashi, Sato, Yuko, Kimura, Hiroshi, Masuda, Takeshi, Ohtsuki, Sumio, Noi, Kentaro, Ogura, Teru, Morioka, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681014/
https://www.ncbi.nlm.nih.gov/pubmed/31323851
http://dx.doi.org/10.3390/molecules24142620
_version_ 1783441634658091008
author Yamauchi, Soichiro
Kobashigawa, Yoshihiro
Fukuda, Natsuki
Teramoto, Manaka
Toyota, Yuya
Liu, Chenjiang
Ikeguchi, Yuka
Sato, Takashi
Sato, Yuko
Kimura, Hiroshi
Masuda, Takeshi
Ohtsuki, Sumio
Noi, Kentaro
Ogura, Teru
Morioka, Hiroshi
author_facet Yamauchi, Soichiro
Kobashigawa, Yoshihiro
Fukuda, Natsuki
Teramoto, Manaka
Toyota, Yuya
Liu, Chenjiang
Ikeguchi, Yuka
Sato, Takashi
Sato, Yuko
Kimura, Hiroshi
Masuda, Takeshi
Ohtsuki, Sumio
Noi, Kentaro
Ogura, Teru
Morioka, Hiroshi
author_sort Yamauchi, Soichiro
collection PubMed
description Single-chain Fv (scFv) antibodies are recombinant proteins in which the variable regions of the heavy chain (VH) and light chain (VL) are connected by a short flexible polypeptide linker. ScFvs have the advantages of easy genetic manipulation and low-cost production using Escherichia coli compared with monoclonal antibodies, and are thus expected to be utilized as next-generation medical antibodies. However, the practical use of scFvs has been limited due to low homogeneity caused by their aggregation propensity mediated by inter-chain VH-VL interactions. Because the interactions between the VH and VL domains of antibodies are generally weak, individual scFvs are assumed to be in equilibrium between a closed state and an open state, in which the VH and VL domains are assembled and disassembled, respectively. This dynamic feature of scFvs triggers the formation of dimer, trimer, and larger aggregates caused by the inter-chain VH-VL interactions. To overcome this problem, the N-terminus and C-terminus were herein connected by sortase A-mediated ligation to produce a cyclic scFv. Open-closed dynamics and aggregation were markedly suppressed in the cyclic scFv, as judged from dynamic light scattering and high-speed atomic force microscopy analyses. Surface plasmon resonance and differential scanning fluorometry analysis revealed that neither the affinity for antigen nor the thermal stability was disrupted by the scFv cyclization. Generality was confirmed by applying the present method to several scFv proteins. Based on these results, cyclic scFvs are expected to be widely utilized in industrial and therapeutic applications.
format Online
Article
Text
id pubmed-6681014
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66810142019-08-09 Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions Yamauchi, Soichiro Kobashigawa, Yoshihiro Fukuda, Natsuki Teramoto, Manaka Toyota, Yuya Liu, Chenjiang Ikeguchi, Yuka Sato, Takashi Sato, Yuko Kimura, Hiroshi Masuda, Takeshi Ohtsuki, Sumio Noi, Kentaro Ogura, Teru Morioka, Hiroshi Molecules Article Single-chain Fv (scFv) antibodies are recombinant proteins in which the variable regions of the heavy chain (VH) and light chain (VL) are connected by a short flexible polypeptide linker. ScFvs have the advantages of easy genetic manipulation and low-cost production using Escherichia coli compared with monoclonal antibodies, and are thus expected to be utilized as next-generation medical antibodies. However, the practical use of scFvs has been limited due to low homogeneity caused by their aggregation propensity mediated by inter-chain VH-VL interactions. Because the interactions between the VH and VL domains of antibodies are generally weak, individual scFvs are assumed to be in equilibrium between a closed state and an open state, in which the VH and VL domains are assembled and disassembled, respectively. This dynamic feature of scFvs triggers the formation of dimer, trimer, and larger aggregates caused by the inter-chain VH-VL interactions. To overcome this problem, the N-terminus and C-terminus were herein connected by sortase A-mediated ligation to produce a cyclic scFv. Open-closed dynamics and aggregation were markedly suppressed in the cyclic scFv, as judged from dynamic light scattering and high-speed atomic force microscopy analyses. Surface plasmon resonance and differential scanning fluorometry analysis revealed that neither the affinity for antigen nor the thermal stability was disrupted by the scFv cyclization. Generality was confirmed by applying the present method to several scFv proteins. Based on these results, cyclic scFvs are expected to be widely utilized in industrial and therapeutic applications. MDPI 2019-07-18 /pmc/articles/PMC6681014/ /pubmed/31323851 http://dx.doi.org/10.3390/molecules24142620 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yamauchi, Soichiro
Kobashigawa, Yoshihiro
Fukuda, Natsuki
Teramoto, Manaka
Toyota, Yuya
Liu, Chenjiang
Ikeguchi, Yuka
Sato, Takashi
Sato, Yuko
Kimura, Hiroshi
Masuda, Takeshi
Ohtsuki, Sumio
Noi, Kentaro
Ogura, Teru
Morioka, Hiroshi
Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions
title Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions
title_full Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions
title_fullStr Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions
title_full_unstemmed Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions
title_short Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions
title_sort cyclization of single-chain fv antibodies markedly suppressed their characteristic aggregation mediated by inter-chain vh-vl interactions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681014/
https://www.ncbi.nlm.nih.gov/pubmed/31323851
http://dx.doi.org/10.3390/molecules24142620
work_keys_str_mv AT yamauchisoichiro cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT kobashigawayoshihiro cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT fukudanatsuki cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT teramotomanaka cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT toyotayuya cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT liuchenjiang cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT ikeguchiyuka cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT satotakashi cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT satoyuko cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT kimurahiroshi cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT masudatakeshi cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT ohtsukisumio cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT noikentaro cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT ogurateru cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions
AT moriokahiroshi cyclizationofsinglechainfvantibodiesmarkedlysuppressedtheircharacteristicaggregationmediatedbyinterchainvhvlinteractions